Agios Pharmaceuticals, Inc. (AGIO)
32.60
-0.49
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
32.33
-0.27
(-0.83%)
After-Hours: 19:58
Agios Pharmaceuticals Market Cap : 1.943B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.972B |
| August 20, 2026 | 2.005B |
| August 19, 2026 | 2.093B |
| August 18, 2026 | 2.050B |
| August 17, 2026 | 2.005B |
| August 14, 2026 | 2.000B |
| August 13, 2026 | 1.995B |
| August 12, 2026 | 2.039B |
| August 11, 2026 | 1.948B |
| August 10, 2026 | 1.943B |
| August 07, 2026 | 1.923B |
| August 06, 2026 | 1.904B |
| August 05, 2026 | 1.891B |
| August 04, 2026 | 1.884B |
| August 03, 2026 | 1.820B |
| July 31, 2026 | 1.789B |
| July 30, 2026 | 1.952B |
| July 29, 2026 | 2.087B |
| July 28, 2026 | 2.145B |
| July 27, 2026 | 2.204B |
| July 24, 2026 | 2.158B |
| July 23, 2026 | 2.153B |
| July 22, 2026 | 2.139B |
| July 21, 2026 | 2.217B |
| July 20, 2026 | 2.377B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.351B |
| July 16, 2026 | 2.298B |
| July 15, 2026 | 2.366B |
| July 14, 2026 | 2.369B |
| July 13, 2026 | 2.406B |
| July 10, 2026 | 2.447B |
| July 09, 2026 | 2.539B |
| July 08, 2026 | 2.537B |
| July 07, 2026 | 2.612B |
| July 06, 2026 | 2.219B |
| July 02, 2026 | 2.230B |
| July 01, 2026 | 2.200B |
| June 30, 2026 | 2.202B |
| June 29, 2026 | 2.257B |
| June 26, 2026 | 2.249B |
| June 25, 2026 | 2.148B |
| June 24, 2026 | 2.153B |
| June 23, 2026 | 2.112B |
| June 22, 2026 | 2.083B |
| June 18, 2026 | 2.027B |
| June 17, 2026 | 1.963B |
| June 16, 2026 | 1.889B |
| June 15, 2026 | 1.888B |
| June 12, 2026 | 1.748B |
| June 11, 2026 | 1.704B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Biogen, Inc. | 32.21B |
| Insmed, Inc. | 27.07B |
| Liquidia Corp. | 6.261B |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
Market Cap Related Metrics
| PS Ratio | 19.45 |
| Price to Book Value | 1.894 |
| Price | 32.60 |
| Earnings Yield | -21.50% |